Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists.

“The cannabinoid receptor type 2 (CB2), is a class A GPCR that was cloned in 1993 while looking for an alternate receptor that could explain the pharmacological properties of 9- tetrahydrocannabinol. CB2 was identified among cDNAs based on its similarity in amino-acid sequence to the CB1 receptor and helped provide an explanation for the established effects of cannabinoids on the immune system.

In addition to the immune system, CB2 has widespread tissue expression and has been found in brain, PNS and GI tract. Several “mixed” cannabinoid agonists are currently in clinical use primarily for controlling pain and it is believed that selective CB2 agonism may afford a superior analgesic agent devoid of the centrally mediated CB1 effects.

Thus, selective CB2 receptor agonists represent high value putative therapeutics for treating pain and other disease states. In this perspective, we seek to provide a concise update of progress in the field.”

http://www.ncbi.nlm.nih.gov/pubmed/23865723

CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons.

“The transient receptor potential vanilloid type 1 channel (TRPV1) and nerve growth factor (NGF) are important mediators of inflammatory pain…

Cannabinoids, by activating CB1 G protein-coupled receptors, produce analgesia in a variety of pain models, though the exact mechanisms are not known. We tested the hypothesis that activation of the CB1 receptor by cannabinoids attenuates NGF-induced TRPV1 sensitization….

These results support the hypothesis that cannabinoids, acting through CB1 receptors, may produce analgesia in part by preventing NGF-induced sensitization of TRPV1 in afferent nociceptor nerve endings.”

http://www.ncbi.nlm.nih.gov/pubmed/23850608

Pot Users Less Likely to Take Painkiller

“Marijuana and hydrocodone are two of the most widely used and abused drugs in the U.S. But according to a new study by one of the nation’s largest drug screening companies, chronic pain patients who are prescribed hydrocodone are less likely to take the painkiller if they are using marijuana.”

More: http://americannewsreport.com/nationalpainreport/pot-users-less-likely-to-take-painkiller-8819408.html

Marijuana Vaporizer Provides Same Level Of THC, Fewer Toxins, Study Shows

“A smokeless cannabis-vaporizing device delivers the same level of active therapeutic chemical and produces the same biological effect as smoking cannabis…

…smoked cannabis can alleviate the chronic pain caused by HIV-related neuropathy, but a concern was expressed that smoking cannabis was not safe. This study demonstrates an alternative method that gives patients the same effects and allows controlled dosing but without inhalation of the toxic products in smoke,” said study lead author Donald I. Abrams, MD, UCSF professor of clinical medicine.

…pills tend to provide patients with more THC than they need for optimal therapeutic effect and increase side effects.

Patients rated the “high” they experienced from both smoking and vaporization and there was no difference between the two methods by patient self-report of the effect, according to study findings. In addition, patients were asked which method they preferred.

“By a significant majority, patients preferred vaporization to smoking, choosing the route of delivery with the fewest side effects and greatest efficiency,” said Benowitz.”

Read more: http://www.sciencedaily.com/releases/2007/05/070515151145.htm

The endocannabinoid system and its therapeutic exploitation.

Image result for Nat Rev Drug Discov.

“The term ‘endocannabinoid’ – originally coined in the mid-1990s after the discovery of membrane receptors for the psychoactive principle in Cannabis, Delta9-tetrahydrocannabinol and their endogenous ligands – now indicates a whole signalling system that comprises cannabinoid receptors, endogenous ligands and enzymes for ligand biosynthesis and inactivation. This system seems to be involved in an ever-increasing number of pathological conditions. With novel products already being aimed at the pharmaceutical market little more than a decade since the discovery of cannabinoid receptors, the endocannabinoid system seems to hold even more promise for the future development of therapeutic drugs. We explore the conditions under which the potential of targeting the endocannabinoid system might be realized in the years to come.”  http://www.ncbi.nlm.nih.gov/pubmed/15340387

http://www.nature.com/nrd/journal/v3/n9/full/nrd1495.html

Using medical marijuana to ease pain

“NORWICH, Conn. (WTNH) –The 31-year-old Norwich man was arrested for growing marijuana inside his home, but says he was only trying to ease his pain.

Tuesday, a Norwich man was in court facing drug charges. Wednesday, he felt comfortable enough to show News 8 how he uses medical marijuana to ease his pain.

31-year-old Joseph Tamborra says the effects are immediate.

“What is the difference after you take a hit,” asked News 8’s Tina Detelj.

“Uhhh it just takes my nausea completely away. It’s like night and day,” Tamborra said.

Relief from nausea caused by his Crones Disease and the pain from a hip and back injury after a car accident.

“I don’t have any cartilage in my hip,” Tamborra said.

It was too much to take, so he took matters into his own hands growing pot plants in a second floor bedroom of his Norwich home. However, that’s illegal and he was arrested for possession and operating a drug factory.

While his court case continued he received his medical marijuana card in March. A picture shows him after losing 90 pounds, unable to smoke after his arrest and too nauseous to eat.

“That helped me out like tremendously,” he said. “Once they realized okay there’s a reason for him doing this.”

At New London Superior Court Tamborra was ordered to perform community services and the charges will go away, but he’s still faced with a dilemma. He says because the medical marijuana law is so new there’s no process in place for him to buy the medical marijuana.

“Hopefully mid-summer, by the end of the year, they might have a dispensary or two set up,” Tamborra said. “I’ve also heard they might just limit it to pharmacies, I’m not really sure.”

The state says it is still working on how the medical marijuana will be dispensed and who can be a licensed producer.”

-Tina Detelj

http://www.wtnh.com/dpp/news/new_london_cty/using-medical-marijuana-to-ease-pain#.UYu7Dcp48Qs

 

Marijuana’s Medicinal Value Vindicated Once Again, This Time For The Elderly

Image Credit: Photos.com

Lee Rannals for redOrbit.com – Your Universe Online

“Researchers from Tel Aviv University say that smoking a little marijuana could help provide dramatic relief for the elderly who suffer from a variety of chronic ailments.

The scientists tested the effects of marijuana treatment on 19 residents of the Hadarim nursing home in Israel. During the study, the participants reported dramatic physical results, including healthy weight gain and the reduction of pain and tremors.

According to the study authors, the elderly participants also experienced an immediate improvement in their moods and communication skills after smoking cannabis.

Zach Klein, a graduate of Tel Aviv University’s Department of Film and Television Studies, said that the use of prescription medications was also significantly reduced as a result of using medical marijuana

The active ingredient in marijuana THC was first discovered in Israel by professors Raphael Mechoulam and Yechiel Gaoni. Israel is known as the world leader in medical cannabis research, according to Klein.

During the nursing home study, 19 patents between the ages of 69 and 101 were treated with medical cannabis in the form of powder, oil, vapor or smoke three times daily over the course of a year for conditions like chronic pain, lack of appetite, and muscle spasms and tremors.

Both researchers and nursing home staff members monitored participants for signs of improvement in their conditions as well as their overall quality of life.

Seventeen of the study participants achieved a healthy weight during their use of marijuana and experienced a noticeable reduction in pain, muscle spasms, joint stiffness and tremors. Nearly all of the patients using cannabis slept better, longer and had a reduced incidence of nightmares and flashbacks related to Post-Traumatic Stress Disorder (PTSD).

The researchers also reported a decline in the amount of prescribed medications taken by patients, such as antipsychotics, Parkinson’s treatment, mood stabilizers and pain relievers. Towards the end of the study, researchers found that 72 percent of participants were able to reduce their drug intake by an average of 1.7 medications per day.

For the next phase of his research, Klein wants to study the connection between medical cannabis and an improved ability to swallow. Difficulties in swallowing can lead to a decline in nutrition and, ultimately, premature death. He believes that cannabis will have a positive impact on patients suffering from this disorder, which is known in medical jargon as dysphagia.”

http://www.redorbit.com/news/health/1112770306/medical-benefits-of-marijuana-elderly-012413/

Medical cannabis eases pain, improves appetite

“Medical Cannabis treatment can improve appetite, ease chronic pain, and more, researchers say.

Though controversial, medical cannabis has been gaining ground as a valid therapy, offering relief to suffers of diseases such as cancer, Post-Traumatic Stress Disorder, ALS and more.

The substance is known to soothe severe pain, increase the appetite, and ease insomnia where other common medications fail.”

http://articles.timesofindia.indiatimes.com/2013-01-25/health/36547301_1_medical-cannabis-chronic-pain-muscle-spasms

Medical cannabis can improve appetite, ease chronic pain, say researchers

“Though controversial, medical cannabis has been gaining ground as a valid therapy, offering relief to suffers of diseases such as cancer, Post-Traumatic Stress Disorder, ALS and more. The substance is known to soothe severe pain, increase the appetite, and ease insomnia  where other common medications fail.

In 2009, Zach Klein, a graduate of Tel Aviv University’s Department of Film and Television Studies, directed the documentary Prescribed Grass. Through the process, he developed an interest in the scientific research behind medical marijuana, and now, as a specialist in policy-making surrounding medical cannabis and an MA student at TAU’s Porter School of Environmental Studies, he is conducting his own research into the benefits of medical cannabis.

Using marijuana from a farm called Tikkun Olam – a reference to the Jewish concept of healing the world – Klein and his fellow researchers tested the impact of the treatment on 19 residents of the Hadarim nursing home in Israel. The results, Klein says, have been outstanding. Not only did participants experience dramatic physical results, including healthy weight gain and the reduction of pain and tremors, but Hadarim staff saw an immediate improvement in the participants’ moods and communication skills. The use of chronic medications was also significantly reduced, he reports.”

Read more: http://www.news-medical.net/news/20130125/Medical-cannabis-can-improve-appetite-ease-chronic-pain-say-researchers.aspx

[Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain–a randomized controlled trial].

“The aim of this study was to investigate the efficacy and efficiency of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain. Of major interest were the evaluation of the influence the treatment had on pain and on quality of life as well as the subjective assessment of positive effects and side effects by the study participants…

CONCLUSION:

In summary, the study results allow the conclusion that a majority of patients with chronic pain classify nabilone intake in addition to the standard treatment as a measure with a positive individual benefit-riskratio. Thus, this kind of treatment may be an interesting and attractive enrichment of analgetic therapy concepts.”

http://www.ncbi.nlm.nih.gov/pubmed/16855921